The biosimilar market was USD 37,270.20 million in 2022, & it is expected to reach USD 343,520.90 million by 2030, with a CAGR of 32.00% during the forecast period.
The biosimilar market was USD 37,270.20 million in 2022, & it is expected to reach USD 343,520.90 million by 2030, with a CAGR of 32.00% during the forecast period.